Related Experiment Video
Updated: Jun 28, 2026

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
Published on: January 18, 2019
Predictive role of BNP and NT-proBNP in hemodialysis patients
Linlin Sun1, Yan Sun, Xuezhi Zhao
1Division of Nephrology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China. pierre_delanaye@yahoo.fr
Insights
Brain natriuretic peptide (BNP) and NT-proBNP levels predict cardiovascular events in end-stage renal disease (ESRD) patients undergoing dialysis. NT-proBNP demonstrated superior predictive value for mortality compared to BNP.
Area of Science:
- Nephrology
- Cardiology
- Biomarkers
Background:
- Cardiovascular events (CVE) are a leading cause of death in end-stage renal disease (ESRD) patients.
- Prognostic factors for CVE in ESRD patients, particularly those on hemodialysis, require further investigation.
- Patients with ESRD are often excluded from cardiovascular clinical trials.
Purpose of the Study:
- To investigate the prognostic value of B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) in predicting cardiovascular outcomes in hemodialysis patients with ESRD.
- To assess the predictive accuracy of BNP and NT-proBNP for cardiovascular mortality, heart failure, and myocardial infarction in this population.
Main Methods:
- Prospective study of 217 ESRD patients on hemodialysis.
- Baseline assessment of BNP, NT-proBNP, dialysis adequacy indices, and biochemical markers.
- Follow-up for 2 years to record cardiovascular events (CVE), including cardiovascular death, myocardial infarction, heart failure, and stroke.
Main Results:
- Both BNP and NT-proBNP were significant predictors of cardiovascular mortality and fatal/nonfatal congestive heart failure (CHF).
- NT-proBNP showed a stronger association with fatal/nonfatal myocardial infarction (MI) compared to BNP.
- NT-proBNP exhibited a significantly better predictive value for mortality than BNP, as indicated by the area under the ROC curve (0.83 vs. 0.61).
Conclusions:
- BNP and NT-proBNP are highly sensitive and specific biomarkers for predicting cardiovascular events in dialysis patients with ESRD.
- NT-proBNP offers superior prognostic capability for mortality in this patient cohort compared to BNP.
Background:
Cardiovascular events (CVE) are a major cause of morbidity and mortality in end-stage renal disease (ESRD) patients. These patients are often excluded from CV clinical trials, and the prognostic factors associated with CVE in patients with ESRD have not been fully explored. We investigated the role of BNP and NT-proBNP in predicting the outcome and prognostic value in hemodialysis with ESRD patients.
Methods:
Baseline NT-proBNP and BNP, indices of dialysis adequacy, and biochemical characteristics were assessed in 217 dialysis patients with ESRD who were followed prospectively for 2 years or until death. CVE included cardiovascular death, myocardial infarction, heart failure and stroke.
Results:
Using multivariable Cox regression analysis, BNP and NT-proBNP remained predictive of cardiovascular mortality (BNP: hazard ratio 1.22, 95% confidence interval (CI) 1.21-11.04, p < 0.05; NT-proBNP hazard ratio 1.86, 95% CI 1.14-9.36, p < 0.05), fatal/nonfatal CHF (BNP: 1.35, 1.33-11.78, p < 0.05; NT-proBNP: 2.25, 1.54-12.68, p < 0.001) and fatal/nonfatal MI (BNP: 0.61, 2.38-19.53, p = 0.42; NT-proBNP: 1.90, 3.28-20.17, p < 0.001). NT-proBNP had better predictive value than BNP for mortality (area under the ROC curve (AUC) 0.83 vs. 0.61; p < 0.05).
Conclusion:
These data showed that BNP and NT-proBNP are very sensitive and specific predictors of CVE in dialysis patients.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemodialysis III: Nursing Management
Diabetic Nephropathy
Chronic Kidney Disease III: Interprofessional Care
Peritoneal Dialysis III: Nursing Management
Serum Studies: Renal Function Tests